Injectable hydrogel relieves osteoarthritis pain and repairs cartilage in preclinical tests
SMRTR summary
Yale researchers discovered that lacosamide, an existing epilepsy drug, can both relieve osteoarthritis pain and repair cartilage by blocking an overactive protein called Nav1.7. Delivered via an injectable smart gel that slowly releases the drug over weeks, a single monthly injection outperformed daily oral medication in preclinical trials.
SMRTR provides this summary for quick context. The original article belongs to Reddit.
Read the original article